Bone Biologics Corp - BBLG
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | New | 23,879 | 32 | 0.0% | — | 1 | +23,879 | New | Q2 2026 | Sep 02, 2026 |
| Tower Research Capital LLC (TRC) | History | Reduced | 1,953 | 2 | 0.0% | 0.0% | 2 | -2,173 | -52.67% | Q2 2026 | Aug 11, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | — | — | -56 | -100.0% | Q2 2026 | Aug 13, 2026 |
| SBI Securities Co., Ltd. | History | No change | 230 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Jul 22, 2026 |